The impact of onabotulinumtoxinA on severe headache days: PREEMPT 56-week pooled analysis

The impact of onabotulinumtoxinA on severe headache days: PREEMPT 56-week pooled analysis

Abstract Background OnabotulinumtoxinA has been shown to reduce headache-days among patients with chronic migraine (CM). The objective of this analysis was to determine whether onabotulinumtoxinA has an impact on headache-day severity in patients with CM among those patients who were deemed non-resp...

Full description

Bibliographic Details
Main Authors: Manjit Matharu, Rashmi Halker, Patricia Pozo-Rosich, Ronald DeGryse, Aubrey Manack Adams, Sheena K. Aurora
Format: Article
Language:English
Published: BMC 2017-08-01
Series:The Journal of Headache and Pain
Subjects:
Chronic migraine
OnabotulinumtoxinA
Headache severity
Hit-6
PREEMPT
Online Access:http://link.springer.com/article/10.1186/s10194-017-0784-4

Internet

http://link.springer.com/article/10.1186/s10194-017-0784-4

Similar Items